L-Serine

( DrugBank: Serine, L-Serine / KEGG DRUG: Serine, Serine )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	2

2. 筋萎縮性側索硬化症

臨床試験数 : 645 / 薬物数 : 589 - (DrugBank : 163) / 標的遺伝子数 : 150 - 標的パスウェイ数 : 225

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03580616 (ClinicalTrials.gov)	October 24, 2018	26/6/2018	Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)	Tolerability and Efficacy of L-Serinein Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Stu ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: L-Serine	Elijah W. Stommel	Brain Chemistry Labs, Institute for Ethnomedicine	Suspended	18 Years	N/A	All	50	Phase 2	United States
2	NCT01835782 (ClinicalTrials.gov)	January 2013	27/3/2013	Determining the Safety of L-serine in ALS	Determining the Safety of L-Serinein Subjects With Amyotrophic Lateral Sclerois (ALS) at Varied Dose ...	Amyotrophic Lateral Sclerosis (ALS)	Drug: L-Serine	Phoenix Neurological Associates, LTD	Institute for Ethnomedicine	Active, not recruiting	18 Years	85 Years	Both	20	Phase 1/Phase 2	United States

First Previous1Next Last